National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

anti-human chorionic gonadotropin vaccine
A peptide vaccine consisting of the whole or partial beta subunit of human chorionic gonadotrophin hormone (hCG), linked to an adjuvant carrier of bacterial or viral origin, with anti-fertility activity. Anti-human chorionic gonadotropin vaccine blocks the activity of hCG which is naturally produced by the trophectoderm of the pre-implantation embryo within a few days of fertilization. hCG is required for the maintenance of the corpus luteum in the ovary thus ensuring its continued production of progesterone, which is required for the successful completion of implantation of the blastocyst. Without progesterone, the corpus luteum regresses, and menstruation is initiated. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)




Previous:anti-FLT-1 ribozyme, anti-GP-3 monoclonal antibody, anti-HER3 monoclonal antibody U3-1287, anti-HGF monoclonal antibody SCH900105, anti-HIF-1alpha LNA antisense oligonucleotide EZN-2968
Next:anti-IGF-1 receptor human monoclonal antibody R1507, anti-IGF-1R fully human monoclonal antibody AMG-479, anti-IGF-1R recombinant monoclonal antibody BIIB022, anti-IGF-1R recombinant monoclonal antibody MK-0646, anti-IGF-1R recombinant monoclonal antibody SCH 717454

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov